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Resveratrol has gained tremendous interest owing to multiple reported health-beneﬁcial effects. How-
ever, the underlying key mechanism of action of this natural product remained largely controversial.
Here, we demonstrate that under physiologically relevant conditions major biological effects of resver-
atrol can be attributed to its generation of oxidation products such as reactive oxygen species (ROS). At
low nontoxic concentrations (in general o50 mM), treatment with resveratrol increased viability in a set
of representative cell models, whereas application of quenchers of ROS completely truncated these
beneﬁcial effects. Notably, resveratrol treatment led to mild, Nrf2-speciﬁc gene expression reprogram-
ming. For example, in primary epidermal keratinocytes derived from human skin this coordinated
process resulted in a 1.3-fold increase of endogenously generated glutathione (GSH) and subsequently in
a quantitative reduction of the cellular redox environment by 2.61 mV mmol GSH per g protein. After
induction of oxidative stress by using 0.78% (v/v) ethanol, endogenous generation of ROS was conse-
quently reduced by 24% in resveratrol pre-treated cells. In contrast to the common perception that re-
sveratrol acts mainly as a chemical antioxidant or as a target protein-speciﬁc ligand, we propose that the
cellular response to resveratrol treatment is essentially based on oxidative triggering. In physiological
microenvironments this molecular training can lead to hormetic shifting of cellular defense towards a
more reductive state to improve physiological resilience to oxidative stress.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Polyphenols represent a large collection of natural products
featuring health-beneﬁcial effects [1]. Resveratrol (3,5,4′-trihy-
droxy-trans-stilbene, RSV), an antimicrobial phytoalexin originally
found in white hellebore (Veratrum grandiﬂorum O Loes) and later
in red grapes and other plants, is one of the most prominentInc. This is an open access article u
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ry, Max Planck Institute for
ermany.polyphenols. Early studies indicated cancer chemo-preventive
properties of RSV [2]. Over the last 15 years, numerous studies
claimed additional beneﬁts including cardio-protective and anti-
aging effects [3]. Consequently, a number of products based on
RSV have been developed for dietary and dermatological applica-
tion [4,5]. Nevertheless, the efﬁciencies of RSV treatments and
underlying mechanisms of action remained largely controversial.
For example, RSV had been suggested to modulate estrogen re-
ceptor activity [6], or to act as a caloric mimetic by directly in-
creasing the enzymatic activity of the histone deacetylase sirtuin 1
(SIRT1) [7]. Recently, it was shown that inhibition of phospho-
diesterase 4 (PDE4) by RSV increased intracellular amounts of the
hunger signalling molecule cAMP [8]. Notably, the reported in-
teraction of RSV with these and further target proteins was in
many cases low and unspeciﬁc. In general, most of these studies
assumed a proportional dose-response relationship of compounds,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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However, in contrast to the standard pharmacological model,
hundreds of studies reported (in many cases probably un-
consciously) beneﬁcial effects of RSV at “low” but detrimental
outcomes at “high” doses. In general, this potentially counter-
intuitive bi-phasic property of RSV was widely ignored [10]. The
large body of data would nevertheless hint to hormesis, a dose-
response relationship that is characterized by low-dose stimula-
tion and high-dose inhibition, consistent with the Arndt-Schulz
law, Hueppe’s rule and other terms describing a beneﬁcial sti-
mulation (of poisons) at low doses [11,12]. General acceptance of
the hormesis concept for therapeutic application seems to remain
minor, due to generally faint stimulatory effects and the lack of
mechanistic explanation of hormetic phenomena.
Interestingly, polyphenols including RSV are considered as an-
tioxidants mainly owing to chemical properties such as scavenging
of free radicals or due to indirect effects in a given biological
system. Depending on the chemical context RSV and other poly-
phenols can also become pro-oxidative [1], a fact that seems to be
often ignored. Depending on the reaction conditions RSV can be
(auto-) oxidized to generate semiquinones and the relatively
stable 4′-phenoxyl radical; ﬁnally this oxidation process can lead
to production of reactive oxygen species (ROS) [13,14]. Oxidative
reactions of polyphenols are inﬂuenced by changing pH, particu-
larly the presence of hydroxyl anions or organic bases [15,16].
Additionally, metal ions (e.g. iron II ions) facilitate oxidative re-
actions and generation of radicals via the Fenton reaction [17].
The here presented study aimed to explore new aspects and
connect fragmented pieces of the chemical and resulting biological
properties of RSV to contribute to a comprehensive understanding
of the purported health-beneﬁcial effects of RSV.2. Material and methods
2.1. Materials
Chemical compounds were purchased from the following
sources: Resveratrol (RSV; 3,5,4′-trihydroxy-trans-stilbene) and
4-hydroxy-2-nonenal (HNE) from Cayman Chemical (Biomol,
Hamburg, Germany). Reduced glutathione (GSH) was purchased
from Sigma Aldrich (Taufkirchen, Germany). The composition of
Berlin tap water can be retrieved from: http://www.bwb.de.
2.2. Cell culture
Neonatal normal human epidermal keratinocyte cells (NHEK, CC-
2503, Lonza, Basel, Swiss) were isolated from a black, newborn
male. NHEK cells were maintained in keratinocyte growth med-
ium (KGM) containing keratinocyte basal medium (KBM, CC-3101,
Lonza) and KGM SingleQuot Kit Suppl. & Growth Factors (CC-4131,
Lonza). Cells were treated with indicated compounds, vehicle
(controls) were as follows: DMSO for RSV and EtOH for HNE (0.05%
DMSO in case of 50 µM RSV; 0.78% ethanol in case of 25 µM HNE).
GSH was dissolved in cell culture medium. Notably, hydrogen
peroxide applied at low micromolar concentrations (comparable
to HNE) did not produce any signiﬁcant oxidative effects, probably
due to efﬁcient scavenging in the cellular context.
Neonatal normal human dermal ﬁbroblast cells (NHDF, CC-209,
Lonza) were isolated from a Caucasian, newborn male. NHDF cells
were maintained in Dulbecco`s modiﬁed Eagle medium (# 31,966,
Gibco, Life Technologies, Darmstadt, Germany) supplemented with
10% fetal bovine serum (FBS) Medium was renewed every two to
three days and cells were split twice per week. Cells were treated
at 60% conﬂuence with 50 mM RSV or vehicle control.
Human HT-29 colon cells (ACC-299, DSMZ, Braunschweig,Germany) were cultured in Dulbecco's Modiﬁed Eagle Medium/
Nutrient Mixture F-12 (DMEM/F-12, # 11,330–057, Gibco, Life
Technologies) supplemented with 5% FBS and 100 U/ml penicillin
and 100 mg/ml streptomycin (all Biochrom, Berlin, Germany). Hu-
man THP-1 monocyte cells (ATCC, LGC Standards GmbH, Wesel,
Germany) were cultivated in RPMI 1640 (Biochrom) supplemented
with 10% FBS and 100 U/ml penicillin and 100 mg/ml streptomycin.
Human HepG2 liver cells (ATCC, LGC Standards GmbH), human
embryonic kidney (HEK293T) cells (ATCC, LGC Standards GmbH)
and human HeLa cells (ATCC, LGC Standards GmbH) were cultured
in DMEM (# 31,966, Gibco, Life Technologies) supplemented with
10% FBS and 100 U/ml penicillin and 100 mg/ml streptomycin. Cells
were seeded into 12-well plates (# 3513, Corning, Fisher Scientiﬁc,
Schwerte, Germany) and treated with RSV or vehicle control.
Human adult low calcium high temperature keratinocyte cells
(HaCaT) and ARE clone 7 HaCaT cells were kindly provided by
Unilever (Sharnbrook, U.K.). ARE clone 7 HaCaT cells were revived
in DMEM (# 31966, Gibco, Life Technologies) supplemented with
10% FBS. The next day, culture medium was changed to selective
medium (DMEM with 10% FBS and 400 mg/ml Hygromicin B (#
10687-010, Life Technologies)) for continued growth. HaCaT cells
were cultured in DMEM (# 21068-028, Life Technologies) sup-
plemented with 1% FBS, 2 mM L-glutamine (Biochrom), 1 mM
sodium pyruvate (# 11360-039, Life Technologies), 70 mM calcium
chloride (Merck GmbH, Darmstadt, Germany), 100 U/ml penicillin
and 100 mg/ml streptomycin.
All cell lines were maintained at 37 °C in a humidiﬁed 5% CO2
atmosphere and treated at 60% conﬂuence. The following passages
were used: NHEK cells p 1, NHDF cells p 2–5, ARE clone 7 HaCaT
cells p 7, HaCaT cells p 47, HT-29 cells p 27, HepG2 cells p 9, and
HEK293T cells p 23. Hela cells at various passages were kindly
provided by Dr. David Meierhofer.
2.3. Analysis of integrity of RSV
The Fluor-de-Lys SIRT1 Fluorometric Drug Discovery Assay
(BML-AK555–0001, Enzo Life Sciences, Lörrach, Germany) was
used to analyse the integrity of RSV after incubation in diverse
solvents according to manufacturer’s instructions. Brieﬂy, com-
pounds were added to a mixture of NADþ and Fluor-de-Lys (FdL)
peptide in reaction buffer (RB). Reaction was started by addition of
SIRT1 in RB followed by 30 min incubation at 37 °C. Reaction was
stopped by addition of NAM and DeveloperII solution. After ad-
ditional incubation for 45 min at 37 °C, ﬂuorescence was measured
(360/460 nm) using the POLARstar Omega (BMG LABTECH, Or-
tenberg, Germany).
2.4. Time-dependent decay of RSV (cell-free)
The time-dependent decay of RSV in diverse solvents was
analysed using the POLARstar Omega (BMG LABTECH) at 37 °C.
Samples were transferred (100 ml/well) into a UV-Star 96-well
plate (# 655801, Greiner Bio-one, Frickenhausen, Germany) for
kinetic and spectral measurement (between 220 and 720 nm, Δλ
2 nm). Photos of RSV under various conditions (Fig. S1a and b) to
document initial decay overnight were taken after about 17.5 h.
2.5. Measurement of ROS (cell-free)
The CellROX Green dye (C10444, Life Technologies) was used to
quantify the formation of extracellular ROS. The dye exhibits a
high ﬂuorescence response in particular to hydroxyl radicals
(HO). Upon oxidation by ROS and after binding to nucleic acids
the probe exhibits green photostable ﬂuorescence. The CellROX
Green dye is compatible with cell culture medium and requires no
cellular processing, hence it can be used for measurement of ROS
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10 mM/well in presence of 1 mg/ml lambda DNA (Life Technologies)
prior to addition of the indicated compounds. Measurement was
performed in a ﬁnal volume of 150 ml/well in black 96-well plates
(# 655090, Greiner Bio-One). The dye was protected against at-
mospheric oxygen by adding a sealing layer of 100 ml/well mineral
oil (Luxcel Biosciences). Fluorescence intensity (Ex 485/30; Em
530/10) was recorded at 37 °C for 16 h using the POLARstar Omega
(BMG LABTECH). For data analyses in GraphPad Prism 5.0 ﬂuores-
cence signals were background-subtracted and normalized to ve-
hicle control. Finally, signals were plotted in GraphPad Prism
5.0 either using a second order neighbour smoothing (4 neigh-
bours) for kinetic depiction or the area under the curve (AUC) was
calculated for summed depiction.
2.6. Quantiﬁcation of intracellular ROS
Formation of intracellular ROS was quantiﬁed using dye 5-
(and-6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein diacetate
(CM-H2DCFDA, Life Technologies) according to the manufacturer’s
instructions. In detail, NHEK cells were seeded in a 96-well plate
(TPP, Biochrom) with a density of 10,000 cells/well. The following
day, adherent cells were washed once with pre-warmed PBS and
loaded with 50 mM dye diluted in PBS. For successful incorporation
and activation of CM-H2DCFDA, cells were incubated for 30 min at
37 °C. Afterwards, free dye was removed by washing with pre-
warmed PBS. KGM (100 ml/well) was added and cells were once
more incubated for 60 min at 37 °C. Compounds were added as
indicated and ﬂuorescence (Ex 485/30; Em 530/10) was measured
for 16 h of treatment at 37 °C using the POLARstar Omega (BMG
LABTECH).
For quantiﬁcation of intracellular ROS in pre-conditioned
NHEKs, cells were seeded in a 96-well plate (TPP, Biochrom) with a
density of 10,000 cells/well and were pre-treated with 50 mM RSV
or vehicle for 16 h. The following day, adherent cells were washed
once with pre-warmed PBS and loaded with 50 mM dye diluted in
PBS. For successful incorporation and activation of CM-H2DCFDA,
cells were incubated for 30 min at 37 °C. Afterwards, free dye was
removed by washing with pre-warmed PBS. KGM (100 ml/well)
was added and cells were once more incubated for 60 min at 37 °C.
Putative protection of NHEKs against oxidative stress by RSV pre-
treatment was tested by adding ethanol (0.781% v/v) or potent
thiol-scavenger HNE [18] at indicated concentrations. Fluorescence
(Ex 485/30; Em 530/10) was measured for 21 h of treatment using
the POLARstar Omega (BMG LABTECH) at 37 °C. For data analyses
in GraphPad Prism 5.0 ﬂuorescence signals were background-
subtracted and normalized to vehicle control. Finally, signals were
plotted in GraphPad Prism 5.0 using a second order neighbour
smoothing (4 neighbours) for kinetic depiction, or the area under
the curve (AUC) was calculated for summed depiction.
2.7. Analysis of H2O2 generation (cell-free)
To determine generation of hydrogen peroxide (H2O2) the
Amplex Red Glucose/Glucose Oxidase Assay Kit (A22189, Life
Technologies) and the Hydrogen Peroxide Assay Kit (K265-200,
BioVision, BioCat, Heidelberg, Germany) were applied. DMEM
samples were ﬁltered using Amicon Ultra-0.5 Centrifugal Filter
Unit with Ultracel-10 membrane (UFC501024) or MultiScreen Ul-
tracel-10 Filter Plate 10 kD (MAUF01010, both Merck Chemicals).
For each experiment a H2O2 standard curve was generated. Sam-
ples were mixed with provided dye, horseradish peroxidase (HRP)
and RB. Fluorescence was measured after 10–30 min incubation at
RT using the POLARstar Omega (BMG LABTECH).2.8. Analysis of superoxide generation (cell-free)
The MitoSOX Red Mitochondrial Superoxide Indicator
(M36008, Life Technologies) was used to quantify the formation of
superoxide (O2). The dye is readily and speciﬁcally oxidized by
superoxide and exhibits red photostable ﬂuorescence after binding
to nucleic acids. The probe is compatible with cell culture medium
and in combination with lamda DNA (Life Technologies) applicable
for measurement of superoxide generation in a cell-free environ-
ment. The dye was diluted to 10 mM/well in presence of 200 ng/
well lambda DNA (Life Technologies) prior to addition of indicated
compounds. Measurement was performed in a ﬁnal volume of
150 ml/well in black 96-well plates (# 655090, Greiner Bio-One).
The dye was protected against atmospheric oxygen by adding a
sealing layer of 100 ml/well mineral oil (Luxcel Biosciences).
Fluorescence intensity (Ex 485/30; Em 530/10) was recorded for
16 h at 37 °C using the POLARstar Omega (BMG LABTECH). For data
analyses in GraphPad Prism 5.0 ﬂuorescence signals were back-
ground-subtracted and normalized to vehicle control. Finally, sig-
nals were plotted in GraphPad Prism 5.0 using a second order
neighbour smoothing (4 neighbours).
2.9. Viability assay
For determination of cellular viability NHEK cells were seeded
in a black 96-well plate (# 353219, BD Biosciences, Heidelberg,
Germany) with a density of 10,000 cells/well and a ﬁnal volume of
200 ml/well. NHDF, HepG2 and THP-1 cells were seeded in a black
384-well plate (# 3712, Corning, Fisher Scientiﬁc) with a density of
2500 cells/well (NHDF) and 5000 cells/well (HepG2, THP-1), re-
spectively, and a ﬁnal volume of 25 ml/well. The following day,
medium was renewed and cells were treated with the indicated
compounds in a ﬁnal volume of 100 ml/well (NHEK) and 35 ml/well
(NHDF, HepG2, THP-1), respectively. After 16 h of treatment, cell
viability was quantiﬁed using the CellTiter-Fluor Cell Viability
Assay (G6081, Promega, Mannheim, Germany). Fluorescence in-
tensity was measured (410/520 nm) using the POLARstar Omega
(BMG LABTECH). Data were ﬁtted (dashed line) using GraphPad
Prism 5.0 with variable Hill slope according to equation:
( )( )= +
( − )
+ *( )−
Y Bottom
Top Bottom
1 10 logIC X Hill Slope50
Fluorescence intensity values were transformed to the relative
number of cells. IC50 is the concentration required for a 50% in-
hibition of viability.
2.10. RNA isolation, reverse transcription and quantitative real-time
PCR
RNeasy Mini Kit (QIAGEN, Hilden, Germany) was applied to
isolate total RNA according to the manufacturer’s instructions. For
cell lysis 10 ml/ml β-mercaptoethanol was added to RLT buffer.
Genomic DNA was digested on a column using DNase-Set (QIA-
GEN). The concentration of extracted RNA was measured using the
Nanodrop ND-2000 Spectrophotometer (Thermo Fisher Scientiﬁc).
RNA was reversely transcribed into cDNA applying the High Ca-
pacity cDNA Reverse Transcription Kit (Life Technologies) with
random primers. After an initial denaturation at 95 °C for 10 min,
the cDNA was ampliﬁed by 40 cycles of PCR (95 °C, 15 s; 60 °C,
60 s). Quantitative PCR was carried out with the ABI Prism 7900HT
Sequence Detection System using the Power SYBR Green PCR
Master Mix (all Life Technologies). The relative gene expression
levels were normalized using β-actin gene and quantiﬁed by the
2ΔΔCt method [19]. Primer sequences are summarized in Table
S5. Data were analysed using GraphPad Prism 5.0.
A. Plauth et al. / Free Radical Biology and Medicine 99 (2016) 608–622 6112.11. Knockdown of NRF2 or SIRT1 with small interfering RNA
NHEK cells were seeded into 6-well plates (Corning) and
transfected with 30 nM Silencer Pre-designed siRNA Nrf2 (#
16708), Silencer Pre-designed siRNA SIRT1 (# 136457) or Silencer
Select negative control siRNA (# 4390844, all Ambion, Life Tech-
nologies) using Lipofectamin 2000 transfection reagent (#
11668019, Life Technologies). Transfection was carried out in 1 ml
for 48 h in KGM, whereby 0.5 ml KGM were added after 24 h.
Mediumwas then renewed and cells were treated with 50 mM RSV
or vehicle for 16 h prior to RNA and protein collection. Data were
analysed using GraphPad Prism 5.0.
2.12. Genome-wide gene expression analyses
Genome-wide gene expression analyses were executed by AT-
LAS Biolabs GmbH (Berlin, Germany) using HumanHT-12 Expres-
sion BeadChips (Illumina, Eindhoven, The Netherlands). All basic
expression data analyses were carried out applying GenomeStudio
V2011.1 (Illumina). Raw data were background-subtracted and
normalized using the cubic spline algorithm. Processed data were
ﬁltered for signiﬁcant detection (P valuer0.01) and differential
expression vs. vehicle treatment according to the Illumina t-test
error model, and were corrected according to the Benjamini-
Hochberg procedure (P valuer0.05) with the GenomeStudio
software. Gene expression data were submitted to the Gene Ex-
pression Omnibus database (GSE72119).
Gene Set Enrichment Analysis (GSEA) [20] of the RSV gene
expression proﬁles was performed using the following para-
meters: 1000 gene set permutations, weighted enrichment sta-
tistic, and signal-to-noise metric. Microarray data were analysed
using the curated C2 KEGG pathways gene sets (version 4.0, 186
gene sets) from the Molecular Signature Database (MSigDB) (Table
S2).
2.13. Cell cycle analyses
Analyses of cell cycle regulation were performed in NHEK cells
treated with the indicated compounds for 16 h. Trypsinised cells
were ﬁxed in 70% ethanol (v/v) and incubated on ice for 15 min.
Fixed cells were then resuspended in propidium iodide (PI)/RNase
staining solution (# 4087, Cell Signalling Technology, New England
Biolabs, Frankfurt, Germany), incubated for 15 min at RT and
stored at 20 °C until use. Finally, cells were measured in the
Accuri C6 ﬂow cytometer (BD Biosciences). Data analyses were
performed using the Watson pragmatic model in FlowJo 7.6 (Tree
Star).
2.14. Phosphatidylserine externalization (Annexin V) assay
To quantify apoptosis, the externalization of phosphatidylserine
[21] was determined in NHEK cells treated with the indicated
compounds for 16 h by staining with annexin-V-FLUOS and pro-
pidium iodide using the Annexin-V-FLUOS Staining Kit (Roche
Diagnostics, Mannheim, Germany) and subsequent ﬂow cytometry
(Accuri C6, BD Biosciences). Analyses were performed using FlowJo
7.6 (Tree Star).
2.15. Immunoblotting
NHEKs were lysed in 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1%
SDS with protease inhibitors (Roche Diagnostics) and phosphatase
inhibitors (Sigma Aldrich), and sonicated (using a device from
Bandelin electronic, Berlin, Germany). After centrifugation for
10 min at 10,000g, supernatants were stored at 80 °C until use.
Samples were denaturated and separated using a NuPAGE Novex4–12% Bis-Tris gel (Life Technologies) and blotted onto Hybond ECL
nitrocellulose membranes (GE Healthcare, Freiburg, Germany).
Membranes were blocked for 1 h at RT according to the manu-
facturer's protocol and washed in TBS-T (0.1% w/v). Primary anti-
bodies against P-Nrf2 (ab76026, Abcam, Cambridge, UK), Nrf2 (sc-
13032X, Santa Cruz, Heidelberg, Germany), Sirt1 (MAb-063-050,
Diagenode, Seraing, Belgium), P-Sirt1 (# 2314), CDK 4 (# 2906),
cyclin D1 (# 2926), CDK 2 (# 2546), cyclin E2 (# 4132), p21 (#
2947), cyclin A2 (# 4656), caspase 7 (# 9492), cleaved caspase 7 (#
8438), caspase 9 (# 9502), cleaved caspase 9 (# 7237), PARP (#
9542), cleaved PARP (# 5625, all from Cell Signalling Technology)
and b-Actin (sc-47778, Santa Cruz) were diluted in TBS-T (0.1% w/
v) with milk powder and BSA, respectively, according to the
manufacturer's protocol. Membranes were shaken at 4 °C over-
night, washed 3 times with TBS-T (0.1% w/v) and subsequently
incubated with anti-rabbit IgG-HRP (sc-2004, Santa Cruz) and
anti-mouse IgG-HRP (sc-2005, Santa Cruz), respectively, according
to the manufacturer's protocol. Detection was carried out with
Western Lightning ECL solution (Perkin Elmer, Rodgau, Germany).
Membranes were stripped with Restore Plus Western Blot Strip-
ping Buffer (Thermo Scientiﬁc, Life Technologies) for 5–7 min.
Densitometric analysis was performed with FUSION-SL Advance
4.2 MP System (Peqlab, Erlangen, Germany).
2.16. Detection of lipid peroxidation
Click-iT Lipid Peroxidation Imaging Kit-Alexa Fluor 488
(C10446, Life Technologies) was used to determine the develop-
ment of cellular lipid peroxides. Linoleamide alkyne (LAA, alkyne-
modiﬁed linoleic acid) is incorporated into cellular membranes
and oxidized upon lipid peroxidation, eventually resulting in
proteins labelled with an azide-modiﬁed Alexa Fluor 488 dye. In-
creasing ﬂuorescence intensities correspond to enhanced lipid
peroxidation upon treatment. NHEK cells were seeded in 25 cm2
cell culture ﬂasks (Corning) and treated with 50 mM RSV or vehicle
for 16 h in presence of 50 mM LAA. After trypsinisation, cells were
washed with PBS and ﬁxed in 3.7% formaldehyde (v/v) for 15 min
at RT. Cells were washed in PBS, permeabilised by use of 0.5% (v/v)
Triton X-100 in PBS for 10 min and subsequently blocked by
adding 1% BSA (w/v) for 30 min (all at RT). Remaining BSA was
removed by rigorously washing the cells with PBS. Pelleted cells
were then incubated with 500 ml Click-iT reaction cocktail for
30 min at RT according to the manufacturer’s protocol. The Click
reaction was stopped by adding 1% (w/v) BSA/PBS. The cells were
washed and resuspended with PBS. Flow cytometry was per-
formed on the Accuri C6 (BD Biosciences). Data were analysed
using FlowJo 7.6 (Tree Star) and GraphPad Prism 5.0.
2.17. Antioxidant assay
The Antioxidant Assay (# 709001, Cayman Chemical) was
conducted according to the manufacturer’s manual. The assay was
miniaturized to a ﬁnal volume of 60 ml/well. Samples including
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)
standards were mixed with metmyoglobin and chromogen. The
reaction was initiated by adding hydrogen peroxide and incubated
5 min at RT on a shaker. Finally, the absorbance was detected at
405 nm with the POLARstar Omega (BMG LABTECH). Trolox stan-
dard curve was used to convert RSV results into Trolox equivalents
and data were ﬁtted (dashed line) using linear regression model.
Data were analysed using GraphPad Prism 5.0.
2.18. Quenching of RSV effects
NHEK cells were seeded in 150 cm2 cell culture ﬂasks (Corning)
and treated with 50 mM RSV, vehicle alone or in combination with
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cells were subjected to quantitative real-time PCR and measured
in the Accuri C6 ﬂow cytometer (BD Biosciences). Data were ana-
lysed using GraphPad Prism 5.0 and FlowJo 7.6 (Tree Star).
2.19. Intracellular glucose quantiﬁcation
Intracellular concentration of glucose was determined using
the PicoProbe Glucose Fluorometric Assay Kit (K688-100, Biovi-
sion, BioCat). NHEK cells were seeded into 25 cm2 cell culture
ﬂasks (Corning, Fisher Scientiﬁc) and treated with 50 mM RSV or
vehicle for 16 h. Samples were processed according to the manu-
facturer’s instructions and deproteinised using the Deproteinising
Sample Preparation Kit (K808-200, Biovision, BioCat). The assay
was miniaturized to 10% of the initial volume and conducted in a
clear, small-volume 384-well plate (# 784101, Greiner Bio-one).
Fluorescence (535/585 nm) was measured after 45 min at 37°C
using the POLARstar Omega (BMG LABTECH). Samples were nor-
malized to protein content. Data were ﬁtted (dashed line) using
linear regression model in GraphPad Prism 5.0.
2.20. Intracellular pyruvate quantiﬁcation
Intracellular pyruvate concentration was determined using the
Pyruvate Assay Kit (# 700470, Cayman Chemical). NHEK cells were
seeded in 150 cm2 cell culture ﬂasks (Corning) and treated with
50 mM RSV or vehicle for 16 h. Sample preparation was done ac-
cording to the manufacturer’s instructions. Fluorescence (530/
585 nm) was measured after 20 min using the POLARstar Omega
(BMG LABTECH) at 37 °C. Samples were normalized to protein
content. Data were analysed using GraphPad Prism 5.0.
2.21. Intracellular lactate quantiﬁcation
Lactate content was quantiﬁed with the Lactate Assay Kit (#
700510, Cayman Chemical). NHEK cells were seeded in 150 cm2
cell culture ﬂasks (Corning) and treated with 50 mM RSV or vehicle
for 16 h. Sample preparation was done according to the manu-
facturer’s instructions. Fluorescence (530/585 nm) was measured
using the POLARstar Omega (BMG LABTECH) at 37 °C. Samples
were normalized to protein content. Data were analysed using
GraphPad Prism 5.0.
2.22. Analyses of intracellular ADP and ATP
The ADP Colorimetric/Fluorometric Assay Kit (K355-100) and
ATP Colorimetric/Fluorometric Assay Kit (K354-100, both Biovi-
sion, BioCat) were used to quantify intracellular ADP and ATP
content. Brieﬂy, NHEK cells were seeded into 150 cm2 cell culture
ﬂasks (Corning) and treated with 50 mM RSV or vehicle for 16 h.
Flasks were washed once with ice cold PBS prior to harvest using a
dispenser (TPP, Biochrom). Cell suspensions were centrifuged at
1000g for 5 min at 4 °C and resuspended in ice-cold extraction
buffer, aliquoted and stored at 20 °C until usage. The assay was
miniaturized to 10% of the initial volume and conducted in a clear,
small-volume 384-well plate (# 784101, Greiner Bio-one) accord-
ing to the manufacturer’s protocol. Optical density was measured
after 45 min at 37°C at 570 nm using the POLARstar Omega (BMG
LABTECH). Samples were normalized to protein content. Data were
analysed using GraphPad Prism 5.0.
2.23. Intracellular NADþ and NADH quantiﬁcation
Intracellular NADþ and NADH content was analysed using the
colorimetric NAD/NADH Quantitation Kit (Biovision, BioCat) ac-
cording to the manufacturer’s instructions. Brieﬂy, NHEK cellswere seeded into 150 cm2 cell culture ﬂasks (Corning) and treated
with 50 mM RSV or vehicle for 16 h. Flasks were washed once with
ice cold PBS prior to harvest using a dispenser (TPP, Biochrom).
Cell suspensions were centrifuged at 1000g for 5 min at 4 °C and
resuspended in ice-cold extraction buffer. Afterwards, cells were
lysed by two freeze-thaw-cycles, followed by intensive vortexing
and centrifugation at 20,800g for 15 min at 4 °C. Part of the cell
lysate was incubated at 60 °C for 30 min to generate NADþ . Cy-
cling buffer, enzyme mix and developer were added according to
the manufacturer’s protocol. Optical density was measured after
30 min at 660 nm using the POLARstar Omega (BMG LABTECH).
Samples at RT were normalized to protein content. Data were
analysed using GraphPad Prism 5.0.
2.24. Analyses of intracellular NADPþ and NADPH
The NADP/NADPH-Glo Assay Kit (G9081, Promega) was used to
quantify the intracellular NADPþ and NADPH content. NHEK cells
were seeded into 12-well plates and treated with 50 mM RSV or
vehicle for 16 h. The following day, cells were washed once in PBS,
60 ml PBS/well were added and cells were lysed in 60 ml base so-
lution with 1% (w/v) dodecyl(trimethyl)azanium bromide (DTAB,
D8638, Sigma Aldrich). Afterwards, 50 ml lysate were transferred
into a clear 96-well plate to measure NADPþ and NADPH in-
dividually according to the manufacturer’s protocol. Finally, 30 ml
sample were transferred to a white-walled clear-bottom 384-well
plate (# 781098, Greiner Bio-one) and 30 ml of NADP/NADPH-Glo
Detection Reagent were added. Luminescence was measured after
30 min at RT using the POLARstar Omega (BMG LABTECH). Sam-
ples were normalized to protein content. Data were analysed using
GraphPad Prism 5.0.
2.25. Analyses of intracellular reduced and oxidized glutathione
Intracellular reduced (GSH) and oxidized (GSSG) glutathione
were quantiﬁed using the GSH/GSSG-Glo Assay Kit (V6611, Pro-
mega). NHEK cells were seeded in a 96-well plate (TPP) with a
density of 30,000 cells/well. The following day, cells were treated
with 50 mM RSV or vehicle for 16 h. The assay was miniaturized to
25% of the initial volume and conducted according to the manu-
facturer’s protocol. In brief, cell culture medium was removed,
12.5 ml/well Total Glutathione Lysis Reagent or Oxidized Glu-
tathione Lysis Reagent were added and incubated for 5 min at RT
while shaking. Afterwards, 12.5 ml/well Luciferin Generation Re-
agent were added and incubated at RT for 30 min. Samples and
standards were transferred to a white 96-well plate (# 655083,
Greiner Bio-one) and 25 ml Luciferin Detection Reagent were ad-
ded. Luminescence was measured after 15 min at RT using the
POLARstar Omega (BMG LABTECH). Samples were normalized to
protein content. Data were analysed using GraphPad Prism 5.0.
2.26. Oxygen consumption assay
Analyses of oxygen consumption was conducted by using the
cell impermeable, oxygen-sensing ﬂuorophore MitoXpress Xtra
(Luxcel Biosciences). NHEK cells were seeded in 96-well plates
(TPP, Biochrom) with a density of 25,000 cells/well. The day after,
cells were treated with 50 mM RSV or vehicle for 16 h and after-
wards equilibrated for 20 min under CO2-free conditions at 37 °C.
After aspirating cell culture medium, 62.5 nM/well MitoXpress
Xtra diluted in KGM (LONZA) was added. The plate was incubated
for 10 min under CO2-free conditions at 37 °C. Compounds were
added as indicated and each well was sealed with 100 ml HS Mi-
neral Oil (Luxcel Biosciences). Dual-read time-resolved ﬂuores-
cence (TR-F) was measured (380/650 nm) with the POLARstar
Omega (BMG LABTECH) at 37 °C. Lifetime, dual-delay and gate
A. Plauth et al. / Free Radical Biology and Medicine 99 (2016) 608–622 613times were calculated and set according to the manufacturer’s
instructions. Data were analysed using GraphPad Prism 5.0.
2.27. Fluorescence microscopy
NHEK cells were seeded in X-well tissue culture chambers
(Sarstedt, Nürnbrecht, Germany) at a density of 20,000 cells/well.
One day later, adherent cells were treated for 16 h with the in-
dicated compounds. Visualization of MAP1LC3A, Actin, Nrf2,
Keap1, GCLC and GSR was executed as recently described in
Weidner et al. [22]. In brief, cells were washed with PBS (Sigma
Aldrich) and ﬁxed in 4% (v/v) formaldehyde/PBS (Sigma Aldrich)
for 15 min at RT. Cells were washed with PBS (Sigma Aldrich),
permeabilised in 0.3% (v/v) Triton X-100/PBS (PBS-Tx) for 10 min
at RT, washed with PBS and afterwards blocked in 5% (v/v) goat
serum (Sigma Aldrich) in PBS-Tx for 60 min at RT. Afterwards, cells
were incubated with primary antibodies at 4 °C overnight. Primary
antibodies and dilutions were as follows: MAP1LC3A (1:100;
AP1801d-ev-AB, Biovision, BioCat), Nrf2 (1:100; sc-13032X, Santa
Cruz; 1:100), Keap1 (1:100, sc-365626, Santa Cruz), GCLC (1:100,
ab41463, Abcam) and GSR (1:100, sc-133159, Santa Cruz). Subse-
quently, cells were washed with PBS-Tx and stained with anti-
mouse IgG (HþL) F(ab')2 fragment Alexa Fluor 555 Conjugate (#
4409, Cell Signalling Technology) and anti-rabbit IgG (HþL), F(ab')
2 fragment Alexa Fluor 488 Conjugate (# 4412, Cell Signalling
Technology) diluted (1:1000) in 1% (w/v) BSA/PBS-Tx for 1h at RT
in the dark. Cells were washed with PBS for 5 min, and the
MAP1LC3A stained cells were counterstained with F-actin probe
Texas Red-X Phalloidin (1:100, T7471, Life Technologies) for 20 min
at RT in the dark. Cells were washed with PBS, the chamber was
removed from the slide, samples were counterstained with Pro-
Long Gold Antifade Mountant (with DAPI) solution (Life technol-
ogies), a cover slip applied (# 235503704, Duran Group, Wer-
theim/Main, Germany) and incubated at RT for 24 h. Fluorescence
microscope imaging was performed using the LSM700 microscope
(Zeiss, Jena, Germany).
2.28. Redox potential, redox state and redox environment
To calculate the half-cell reduction potential of a selected redox
couple the Nernst equation (Eq. (1)) was used and transformed to
match the experimental conditions (T ¼310K¼37 °C, pH 7) (Eq.
(2)).
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61. 5 mV
2hc
0
R is the gas constant (8.314 J K1 mol1), T the temperature in
Kelvin, n the number of electrons exchanged, F the Faraday con-
stant (9.6485*104 C mol1), and Q the mass action expression. As
the standard reduction potential (E0, E0′) is pH dependent, an ad-
justment is necessary:
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EpH represents the half-cell reduction potential at a given pH,
while ΔE/ΔpH is dependent on the number of electrons and
protons involved. The half-cell reduction potential of a selected
redox couple can eventually be determined according to (Eq. (5)).
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The half-cell reduction potential can be calculated for the fol-
lowing metabolites (redox couples):
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Finally the redox environment was calculated using the redox
couple 2GSH/GSSG alone (Fig. 5a and Table S4) or redox couples
lactate/pyruvate, NADH/NADþ and 2GSH/GSSG (Fig. S7d and Table
S4), respectively.
To relate the reduced redox environment to an oxidative
challenge, we conducted a thought experiment focusing on oxi-
dation of ethanol to acetaldehyde and simultaneous ROS genera-
tion [23–25]:
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In order to estimate the amount of ROS induced by application
of ethanol, which can be minimized by RSV pre-treatment, we
made the following assumptions:
 pH 7,
 T ¼37 °C,
 2GSH/GSSG redox couple is the driving force of the redox en-
vironment and
 Consider concentrations of GSH and GSSG as measured at pH
7.0026 (vehicle) and 7.0632 (RSV), respectively.
At equilibrium, change of the half-cell reduction potentials of
both couples equal 0 and can be transformed appropriately:
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According to Sarkola et al. (2002) [26] the formation of acet-
aldehyde in humans is dependent on the amount of ethanol. The
mean slope can be determined as follows:
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Finally we can calculate QRSV accordingly:
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Thus, we can estimate that owing to RSV pre-treatment and the
resulting shift in redox environment, NHEKs are likely to tolerate
roughly 26% more ethanol than vehicle-treated cells. Notably, in
particular vehicle-treated NHEK cells did not tolerate higher doses
of ethanol without serious reduction of viability. Consequently,
experimental evidence for this thought experiment cannot be
provided completely.
We further challenged RSV pre-treated NHEKs with HNE, a
potent thiol scavenger [18,27,28]. Assuming that one molecule
GSH is needed to detoxify one molecule HNE, we can roughly
estimate the amount of additional HNE quenched owing to in-
creased cellular concentrations of GSH after RSV pre-treatment.
Corresponding to the increasing GSH content (7 mmol per g pro-
tein, roughly 2 mM) due to pre-treatment with RSV, the observed
pre-conditioning effect is depleted at HNE concentrations
Z25 mM. Nevertheless, this is just an approximation, as the GSH
pool regulates the reduction state of many biological molecules
and because HNE can efﬁciently react with many intracellular thiol
groups, lipids and proteins present in the biological system.
2.29. Statistical analyses
Data are expressed as mean7standard error (s.e.m.), if not
otherwise denoted. Statistical tests were performed in GraphPad
Prism 5.0. For comparison of two groups statistical signiﬁcance
was examined by unpaired two-tailed Student’s t-test. One-way
ANOVA with subsequent Dunnett’s post-test was used for multiple
comparisons. A P valuer0.05 was deﬁned as statistically
signiﬁcant.3. Results and discussion
3.1. RSV is unstable under physiologically relevant conditions
The vast majority of studies seem to assume speciﬁc RSV-target
protein interactions, which implies that RSV remains intact during
treatments. However, after incubation in various media containing
physiological concentrations of sodium bicarbonate (NaHCO3), a
key component of water as well as buffer of blood and biological
cells, RSV reacts efﬁciently, as indicated by striking yellowish
colour changes (Fig. S1a and b). Light absorbance at characteristic
RSV maximum (308 nm) decreased rapidly in water and cell cul-
ture media, both containing sodium bicarbonate (Fig. S1c and d,
Table S1). After 16 h incubation the absorption maximum of RSV
was almost completely diminished. Furthermore, using acommonly applied ﬂuorescence-based SIRT1 assay no enzymatic
activation could be detected (Fig. S1e).
Oxidation of RSV at atmospheric oxygen level (21% O2, as
usually applied in cell culture) [16,29] could potentially be con-
sidered as non-physiological as in blood vessels the oxygen
amount is roughly 14% and in tissues or tumours even lower ( 1%
O2) [30]. Our data suggest that the auto-oxidation of RSV is highly
dependent on the presence of sodium bicarbonate and pH of the
solvent [14,31] (see Figs. 1 and 2 in Reference [31]), whereas a
decreased oxygen partial pressure seems to have a comparably
minor inﬂuence (see Figs. 3 and 4 in reference [31]). These data
suggest that oxidation of RSV can to some extent even take place
in hypoxic microenvironments.
These results corroborate widely ignored ﬁndings that the
stability and oxidation of RSV in physiologically relevant media is
strongly inﬂuenced by pH and in particular the availability of hy-
droxyl anions [16,29,32]. Interestingly, RSV reacted also efﬁciently
in tap water (Figs. S1e and S2e left), which might in part explain
the often-reported perplexing low bioavailability of RSV in vivo
[33–35]. Although RSV could potentially be protected from protein
carriers such as serum albumin [36], the entirety of these data
makes it difﬁcult to understand how RSV could exert compound-
protein speciﬁc effects. These results further indicate that meta-
bolisation of RSV, for example by oxidation of the enzymes of the
CYP1 family, might play a minor role in physiological context,
consistent with the usually extremely low amounts of detected
metabolites of RSV [33–35].
3.2. RSV produces ROS under physiologically relevant conditions
We next asked how the oxidizing RSV could induce relevant
biological effects. Notably, treatment of cells with RSV resulted in
time- and concentration-dependent generation of intracellular
ROS (Fig. 1a and b, Fig. S2a).
Owing to the complexity of biological matrices it remains
technically impossible to detect exactly the entirety of unstable
intermediate ROS. However, using deﬁned solvents or a cell-free
environment, we detected signiﬁcantly increased amounts of ROS,
including superoxide (O2), hydroxyl radicals (HO) and hydro-
gen peroxide (Fig. 1c, Fig. S2b-e ) [14,16]. For example, between
5.0 and 12.5 mM hydrogen peroxide (Fig. S2e) was generated de-
pending on the concentration of RSV and sodium bicarbonate (Fig.
S2e left), whereas (metabolic) scavengers such as pyruvate
strongly depleted ROS (Fig. S2e right). As revealed by an anti-
oxidant assay using trolox as control compound, in presence of
sodium bicarbonate the anti-oxidative feature of RSV was clearly
diminished (Fig. S2f left). In contrast, RSV showed roughly 2-fold
higher anti-oxidative capacity in solvents lacking sodium bi-
carbonate (Fig. S2f right). These data suggest that RSV loses in part
its anti-oxidative properties and becomes more pro-oxidative in
physiological media. Notably, low concentrations of oxidation
products of RSV can mildly affect cellular biomolecules such as
proteins and lipids (Fig. 1d).
In summary, these data indicate that oxidation of RSV takes
place under physiologically relevant conditions. These conditions
differ signiﬁcantly from many experimental setups that are ap-
plied to analyse RSV by common bicarbonate-free enzymatic as-
says, and also vary from bicarbonate-free crystallization proce-
dures that are in general used for x-ray analyses.
3.3. Effects on primary human keratinocytes
We next asked how oxidation of RSV might exert biological
effects. Given the here observed oxidative features in particular
topological application of RSV seems a medically relevant ap-
proach, as is also evident from the number of available
Fig. 1. RSV produces ROS and triggers cellular defense. (a and b) Kinetic (a) and summed (b) intracellular generation of ROS in primary NHEK cells after administration of
50 μM RSV. Values are mean7s.e.m. (n¼6); AUC, area under the curve; RFU, relative ﬂuorescence units. (c) Generation of superoxide in H2O and keratinocyte growth
medium (KGM), which both contain sodium bicarbonate (NaHCO3), after addition of 50 μM RSV for indicated time periods. Values are mean7s.e.m. (n¼4). (d) RSV (50 μM)
induced lipid peroxidation in NHEKs. Values are mean7s.e.m. (n¼4); *Po0.05 versus vehicle. (e) Selection of enriched KEGG pathways in NHEKs treated with 50 μM RSV
using gene set enrichment analysis (GSEA). Values are normalized enrichment scores (NES, n¼4 for vehicle, n¼3 for RSV); *Po0.05, **Po0.01, ***Pr0.001 versus vehicle.
See also Table S2. (f) GSH considerably quenched effects of RSV on gene expression. Values are mean7s.e.m. (n¼4); **Po0.01; ***Pr0.001 one-way ANOVA versus RSV.
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study on potential protection of the human epidermis. Notably,
due to ethical considerations and law, for physiological testing
dermatological research applies ex vivo models such as the here
applied primary human keratinocytes that formed the outer layer
of the skin of a patient. Keratinocytes are known to build a tight
layer of cells that can be used as epidermal grafts (Fig. S2g) [37],
and these cells represent a prime target for lotions and emollients
based on RSV [38,39].
Firstly, we investigated potential oxidation of cellular compo-
nents owing to oxidation products of RSV. Sixteen hours of treat-
ment with 50 mM RSV slightly elevated lipid peroxidation in nor-
mal human primary keratinocyte (NHEK) cells, indicating mildly
increased oxidation of cellular biomolecules (Fig. 1d).
Moreover, to globally monitor cellular response to oxidation
products of RSV, genome-wide RNA expression analyses revealed a
slight but signiﬁcantly increased expression of molecular path-
ways covering oxidative stress response and inﬂammatory sig-
nalling, as well as fatty acid metabolism (Fig. 1e and Table S2). Incontrast, processes linked to proliferation, DNA replication and cell
cycle were down-regulated. Importantly, quenching of oxidation
by adding strong reducing molecules such as 25 mM synthetic
GSH signiﬁcantly reversed expression of cell response marker
genes (Fig. 1f). As shown in a control experiment, quenching by
synthetic GSH reduced the levels of ROS derived from RSV in a
cell-free environment (Fig. S2h) and within cells (Fig. S2i), sug-
gesting that these ROS caused the observed gene expression
events. As tested with a small panel of unrelated cell models,
despite cell-speciﬁc defense mechanisms the here observed gene
expression responses seem to some degree be independent from
cellular background (Fig. S3a–d, Table S3).
These data indicate to our knowledge for the ﬁrst time that
major gene expression events induced by RSV can be explicitly at-
tributed to the development of oxidation products, since application
of molecular quenchers suppressed these effects. The oxidative ef-
fects of RSV analysed here in mammalian cells might also underlie
phytoalexin-based protection of plants against microbial infection
[40].
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In a next step, we asked how oxidation products derived from
RSV could potentially inﬂuence viability of cells. Using cell viability
assays, we observed increased cellular ﬁtness up to about 50 mM
RSV in treated NHEKs, whereas higher concentrations tended to
produce toxic effects, leading to a typical bi-phasic, hormetic dose-
viability curve (Fig. 2a and b). Notably, in additional cellular
models for ﬁbroblasts and liver cells we observed similar bi-phasic
dose-viability curves with varying susceptibility to RSV treatment
(Fig. 2c–d). Slight but signiﬁcantly increased expression of mole-
cular markers for oxidative stress response, such as catalase (CAT),
could be observed up to 100 mM RSV with a maximum at 50 mM
RSV (Fig. 2b). On the other hand, too high concentrations of RSV
(4100 mM RSV) resulted in low cell viability (Fig. 2b). In summary,
these data are in line with a large body of mostly unconsciously
reported hormetic cellular effects of RSV [10].
Importantly, the hormetic dose-viability curve was signiﬁcantly
truncated by adding 25 mM synthetic GSH as a quencher, pro-
viding to our knowledge for the ﬁrst time strong evidence that
increased cellular viability mainly derives from ROS and other
oxidation products of RSV (Fig. 2a–d).
Further concentration- and time-dependent treatments of
NHEKs resulted in generally slight up-regulation of a number of
metabolic, aging, oxidative stress and inﬂammation signalling genes
(Figs. 3a–d and S3e–h). Notably, in NHEKs these cellular responses
could be observed in a concentration range of approximately 5–
100 mM RSV. Strong changes in gene expressionwere observed after
at least 12 h, most obviously after 16 h of treatment.
The entirety of the data suggests that under physiological
conditions increased viability of cells was triggered by ROS (and
potentially also other radicals of RSV). Instead of the conventional
pharmacological (linear) threshold model we observed a bi-phasicFig. 2. Hormetic effects are induced by generation of ROS derived from RSV. (a) After 16
of NHEKs at concentrations Z50 μM (IC50: 223.8 μM). RSV effects on viability were co
(b) Dose-response curve of RSV in treated NHEKs (blue). Hormetic zone emerges from
stress response gene catalase (CAT)) were generally observed at 50 μM RSV. (c) RSV
342.5 μM), which was quenched by GSH (IC50: 1163.0 μM). Values are mean7s.e.m. (
centrations Z150 μM (IC50: 445.3 μM), whereas GSH quenched the RSV induced effectsmode of action of RSV: at normally applied non-toxic concentra-
tions, RSV treatment increased cellular ﬁtness owing to expression
of cellular defense genes, whereas higher concentrations of RSV
resulted in toxic effects. The underlying reason for this cellular
behaviour seems to depend largely on the pro-oxidative properties
of RSV. In summary, the here proposed link introduces an explicit
explanation of the so far rather “nebulous” hormetic effects of RSV.
3.5. Hormetic effects of oxidative products derived from RSV are
driven by activation of Nrf2
We next asked how oxidising RSV could induce speciﬁc cellular
response. Especially the nuclear factor (erythroid-derived 2) like 2
(Nrf2) is considered responsible for accommodating oxidative
stress (Fig. S4a) [2,41–43]. Consistent with the above shown pro-
duction of oxidation products of RSV, we observed translocation of
redox-sensitive Nrf2 into the nucleus of NHEKs (Figs. 3e and S4b),
leading to regulation of known Nrf2 target genes (Fig. 3a–d bold
font). Remarkably, knockdown of mRNA expression of Nrf2 gene
by small interfering RNAs (siRNAs) signiﬁcantly decreased the
observed effects of RSV on gene expression response (Figs. 3f and
S5a). This experiment indicates that Nrf2 via its well-established
canonical signalling pathway mediates major response of NHEKs
to the oxidation products of RSV.
ROS and further radicals can produce numerous effects by in-
creasing oxidation of cellular biomolecules, leading for example to
inhibition of protein activity. Thus, we expected multiple defense
mechanisms to counteract ROS including for example autophagy
and cell cycle arrest. Interestingly, RSV treatment slightly in-
creased autophagy, probably to degrade and recycle potentially
damaged cellular components (Figs. 4a and S5b), corroborating
previous observations [44]. Simultaneously, primary NHEKs were
partly arrested in G1 cycle phase (Figs. 4b and S5c). Interestingly,h of treatment RSV increased viability at low concentrations but decreased viability
nsiderably quenched by GSH (IC50: 247,747.0 μM). Values are mean7s.e.m. (n¼3).
1 to 60 μM RSV and highest molecular effects (gene expression peaks of oxidative
started decreasing the viability of NHDF cells at concentrations Z300 μM (IC50:
n¼6). (d) RSV started reducing the viability of human HepG2 liver cells at con-
. Values are mean7s.e.m. (n¼6).
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(Figs. 4c and d, S5d and e) and exhibited reduced necrosis (Fig. 4d).
In the context of slightly increasing molecular stress, the here
observed mechanisms might allow cells to focus their limited re-
sources on cellular repair, while decreasing cellular proliferation
and nucleotide synthesis (Fig. 1e). Notably, similar effects were
reported for mild stress such as calorie restriction to improve
cellular ﬁtness [45,46].
We next asked if and how other reported factors such as the
promiscuously reacting lysine deacetylase sirtuin 1 (SIRT1) could
potentially modulate the effects derived from RSV-based activa-
tion of Nrf2, for example in the context of autophagy.
As shown above, under physiologically relevant conditions the
almost completely degraded RSV can merely directly or allosteri-
cally induce the enzymatic activity of SIRT1 (Fig. S1e). However,Metabolic marker
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Fig. 3. Cellular response to RSV-derived oxidation products including ROS is mediate
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with all gels run under the same experimental conditions and cropped blots are depicted
gene expression after knockdown of Nrf2 in RSV treated (16 h) NHEKs. Values are mean
siRNA vehicle. See also Fig. S5a.the 4-fold up-regulation of SIRT1 expression (Fig. 3b), the phos-
phorylated SIRT1 (Fig. S6a) and the simultaneously increased
NADþ/NADH ratio (Figs. 5a and S7d) might concurrently con-
tribute to modify the mild effects derived from oxidized RSV.
Knockdown of the SIRT1 gene resulted in 20% lower expression of
NRF2, suggesting a potential modifying effect of SIRT1 on Nrf2 (Fig.
S6b). However, at least in NHEKs knockdown of SIRT1 did not
strongly inﬂuence overall gene or protein expression (Fig. S6c and
d), corroborating the major role of Nrf2 in the response to oxida-
tive products of RSV.
3.6. Oxidative products of RSV induce a reduced cellular redox
environment
We then asked how gene expression induced by RSV/ROS-Marker of aging
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In NHEKs treated for 16 h with 50 mM RSV, we observed signalling
events such as increased phosphorylation of pyruvate dehy-
drogenase E1 component subunit alpha (PDE1α) at serine 293 (Fig.
S7a), an effect known to inhibit endogenous pyruvate breakdown
and oxidative phosphorylation [47]. Consequently, this molecular
effect led to increased intracellular levels of the potential ROS-
scavenger pyruvate while lactate remained at constant levels
(Fig. 5a). We further observed under constant mitochondrial bio-
genesis decreased mitochondrial oxygen consumption during 16 h
of RSV treatment (Fig. S7b and c).
Moreover, the intracellular ratio of metabolite couples GSH/
GSSG and ATP/ADP, as well as the amount of glucose and pyruvate,
were signiﬁcantly increased (see Figs. 5a and S7d). Moreover, the
intracellular ratios of metabolite couples NADH/NADþ and
NADPH/NADPþ were signiﬁcantly decreased (Fig. S7d). Consistent
with the ratio of the most relevant GSH/GSSG redox couple, the
expression of genes and proteins related to glutathione metabo-
lism was highly elevated, corresponding to signiﬁcantly raised
levels of the potent cellular antioxidant GSH (Figs. 5a and b, S7d
and e).
In summary, these data indicate a metabolic switch that leads
in particular to an increased pool of reduced glutathione (GSH).
Clearly, the GSH concentration can vary a lot between different cellDAPI MA3CL1PAM
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To explore thermodynamic aspects of the cellular state, we next
analysed the redox environment of NHEKs treated with RSV.
Therefore, we considered intracellular concentrations of above-
mentioned key metabolites, using the Eq. (18) [48].
⎡⎣ ⎤⎦∑
( )
= *
( )=
Redox environment E reduced species
18i
n couple
i i
1
Indeed, via activation of the canonical Nrf2 pathway RSV
treatment at hormetic concentrations increased in particular the
level of endogenously produced GSH. This effect resulted in a shift
of the cellular redox environment to a more reduced state (Fig. 5c
and for calculation-relevant parameters see Table S4) [49]. Based
on the GSH/GSSG couple, which provides the most relevant cel-
lular pool of reducing equivalents [48], we calculated a slight shift
of redox environment of 2.61 mV mmol GSH per gram protein. A
similar trend was observed by taking into account further redox
couples (see also Fig. S7f and Table S4). According to our results,
RSV treatment can eventually contribute to an overall chemical
reduction of biological molecules containing for example thiol
groups, as evident from the increased cellular GSH concentration
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Fig. 5. RSV inﬂuenced the concentration of key metabolites to shift the cellular redox environment to a reduced state, thereby increasing robustness versus oxidative stress.
(a) Shift in intracellular metabolite concentrations after treatment with 50 μM RSV for 16 h in NHEKs. Values are mean7s.e.m. (NADH, NADþ n¼3; glucose, ATP, ADP, GSH,
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be subsumed by the redox environment equation (Eq. (18)) to
explain and quantify a major (thermodynamic) state of the cellular
system. In the ideal case the redox environment of the cell can be
calculated by making use of the full “redoxome” and not only se-
lected metabolite data, which might become possible in the future.
Furthermore, exact knowledge of the concentrations of the various
(reductive) metabolites such as GSH could be used to generate
kinetic molecular networks of the cell.
We ﬁnally analysed if the observed reduced redox environment
could potentially protect the cell from (oxidative) stress. Therefore,
we subjected NHEKs to 16 h pre-treatment with 50 mM RSV. After
replacement of medium the NHEK cells were devoid of any re-
sidual RSV. We then treated NHEKs with 0.78% ethanol and ana-
lysed the endogenous generation of intracellular ROS from cellular
metabolisation of ethanol, i.e. the level of oxidative stress (Fig. 5d)
[24]. Notably, we observed that overall reduced cellular environ-
ment (owing to the increased pool of endogenous GSH) enabled
RSV-pre-treated NHEKs to buffer additional production of ROS
resulting from biotransformation of ethanol (Fig. 5d). The protec-
tive effects of pre-treatment with RSV, i.e. the raise of en-
dogenously produced GSH, were revised in a concentration-de-
pendent manner by addition of 4-hydroxy-2-nonenal (HNE). This
α,β-unsaturated aldehyde mainly acts as a strong electrophile by
depleting cellular sulfhydryl compounds like GSH (Fig. 5d), and
might also interact with Nrf2 [28,50,51].4. Conclusion
Summarizing, we propose a bi-phasic pharmacological model
for RSV, which might also be relevant for other pro-oxidativepolyphenols. This model comprises i) generation of oxidation
products at non-toxic concentrations in physiologically relevant,
sodium bicarbonate-containing media, ii) speciﬁc mediation of
cellular response to pro-oxidative RSV by the redox-sensitive
transcription factor Nrf2 and iii) induction of gene expression
programs resulting in slight reductive shifting of cellular redox-
environment to protect the cell from additional (oxidative) stress
(Fig. 6a and b).
Clearly, the here described model largely depends on the pro-
and anti-oxidative properties of RSV in a given microenvironment.
We argue that bicarbonate containing media are essential for liv-
ing systems (from simple micro- to higher mammalian organ-
isms), and thus it seems that the pro-oxidative features of RSV
might be relevant for a large variety of biological phenomena.
Given that the here shown chemical properties of RSV appear
dominant, we assume that not only mammalian but also microbial
enzymatic conversion of RSV might be probably less important
than previously anticipated. Our data indicate that analysis of the
pro- and anti-oxidative features of RSV shall be thoroughly ex-
plored prior any biological investigation and interpretation.
And what about applications? In particular the human epi-
dermis being predominantly prone to external stress might beneﬁt
from dermatological application of RSV. The here elaborated pro-
oxidative features of RSV and the redox-environment shifting
concept can at least in part explain such recent claims [43]. Of
note, whereas RSV might remain stable under low pH conditions
in the stomach (see Figs. 1 and 2 in Reference [31]), physiologically
well-known neutralization in the duodenum – by high con-
centrations of bicarbonate derived from the pancreas – might in-
duce efﬁcient oxidation of RSV in the intestine.
Considering the increase of endogenously produced GSH and
resulting reduction of the cellular redox environment as the main
Fig. 6. Model and molecular networks involved in RSV-induced cytoprotection against oxidative stress. (a) A dose-dependent compound-target protein model is generally
assumed to explain biological effects of RSV. Our model instead integrates pro-oxidative features of RSV, Nrf2-mediated cellular response and mild beneﬁcial (hormetic)
biological effects at normally applied concentrations. Estrogen R¼estrogen receptor, SIRT1¼silent mating type information regulation 2 homolog 1, PDE4¼pho-
sphodiesterase 4. (b) At low concentrations oxidizing RSV induces mild stress, resulting in a metabolic and redox environment shift to increase the level of endogenous
quenchers such as GSH to eventually protect the cell from environmental stress.
A. Plauth et al. / Free Radical Biology and Medicine 99 (2016) 608–622620phenomena, the often-reported weak and pleiotropic effects of
RSV on biological cells can be described quantitatively and in a
comprehensive manner. On the other hand, in particular the ef-
fects derived from oxidation products with short lifetimes such as
ROS are difﬁcult to trace in vitro and in particular in vivo. This
drawback might provoke scepticism how such “dirty” chemicals
shall exert well-controllable cellular and physiological effects.
Nevertheless, taking a (thermodynamic) systems view we
suggest to apply the here explored paradigm for mathematically
analysing biological effects of pro-oxidative compounds. For ex-
ample, the determination of the redox environment allows for
calculating the oxidation-buffering capacity of targeted cells and
tissues under investigation. Using such a framework and ad-
ditionally establishing kinetic networks, might be helpful ap-
proaches to rationally exploit beneﬁcial bi-phasic effects of pro-
oxidative compounds for therapeutic and preventive application.
For example, this may include development of chemical deriva-
tives of RSV and molecular carriers to efﬁciently guide pro-oxi-
dative molecules to the target tissues of choice.
In general, hormetic induction of cellular ﬁtness by pro-oxi-
dative polyphenols such as RSV might represent a powerfulapproach to protect cells against physiological stress and to inhibit
age-related diseases.Accession codes
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